From Our Special Correspondent
Daijiworld Media Network
Bengaluru, Nov 27: IT/BT and Rural Development Minister Priyank Kharge highlighted the growing Indo-Swiss Biotech Collaboration as Anabio Technologies Pvt. Ltd., a pioneering force in femtech innovation has acquired the Microbe Investigations Switzerland (MIS), a Zurich-based leader in microbial research and diagnostics.
The announcement was made during a special event hosted at Swissnex, Bengaluru on Wednesday.
The event was attended by Priyank Kharge, who lauded the acquisition as a reflection of Karnataka’s burgeoning biotech ecosystem.
Other key leaders from both India and Switzerland including Mr. Jonas Brunschwig, CEO and Consul General of Swissnex, Mithun Shah, CEO of Anabio Technologies, Prof Dr Hendrik Tevaearai, Chairman of the Board, MIS were also present at the event.
The minister, in his address, said “This acquisition is a testament to Karnataka’s thriving biotech ecosystem.
With initiatives like Elevate, Unnati, and world-class infrastructure such as the Bangalore Bioinnovation Centre (BBC), Karnataka is proud to provide a conducive environment for innovation.
“We are committed to supporting companies like Anabio Technologies, who are taking India’s biotech prowess to the global stage," He emphasized the critical role of collaboration between India and Switzerland in advancing biotech research and addressing global challenges,” Kharge said.
The event also marked the launch of a refreshed MIS brand identity, including a new logo and website.
The acquisition is a significant milestone in strengthening the Indo-Swiss partnership in biotechnology, fostering greater collaboration between India and Switzerland in microbial diagnostics, microbiome research, and sustainable innovation.
It will allow Anabio Technologies to enhance its capabilities in areas such as entomology, microbiome research, and environmental sustainability.
With a renewed brand identity, MIS is now poised to scale its operations globally while continuing to drive innovation in microbial diagnostics.
This landmark acquisition signals a new era of collaboration between India and Switzerland, positioning both countries as key players in the global biotech landscape.